Cargando…
The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
Advanced malignant pleural mesothelioma (MPM) has an extremely poor prognosis with limited chemotherapy options, therefore the identification of new therapeutic targets would aid in disease management. Arachidonic acid is metabolised by cyclooxygenase and lipoxygenase enzymes. The lipoxygenase isoen...
Autores principales: | Oguh-Olayinka, Lily, Agarwal, Vijay, Ranatunge, Dulani, Campbell, Anne, Laufer, Stefan, Cawkwell, Lynn, Lind, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242492/ https://www.ncbi.nlm.nih.gov/pubmed/30941737 http://dx.doi.org/10.1007/s12253-019-00652-x |
Ejemplares similares
-
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
por: Dipper, Alex, et al.
Publicado: (2021) -
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
Use of preclinical models for malignant pleural mesothelioma
por: Shamseddin, Marie, et al.
Publicado: (2021) -
BTS guideline for the investigation and management of malignant pleural mesothelioma
por: Woolhouse, Ian, et al.
Publicado: (2018)